UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humans

Scientific reports, 2024-07, Vol.14 (1), p.17515-12, Article 17515

2024

Volltextzugriff (PDF)

Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects

Drug metabolism and disposition, 2002-04, Vol.30 (4), p.430-437

2002

Volltextzugriff (PDF)

HPA Axis Effects of Mometasone Furoate/Formoterol (MF/F) Versus Fluticasone Propionate/Salmeterol (FP/S) Administered via Metered-Dose Inhaler (MDI

Chest, 2012-10, Vol.142 (4), p.685A-685B

2012

Volltextzugriff (PDF)

A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study

The Journal of infectious diseases, 2022-08, Vol.226 (1), p.109-118

2022

Volltextzugriff (PDF)

Ezetimibe : A review of its metabolism, pharmacokinetics and drug interactions

Clinical pharmacokinetics, 2005-01, Vol.44 (5), p.467-494

2005

Volltextzugriff (PDF)

Mometasone furoate nasal spray : A review of safety and systemic effects

Drug safety, 2007-01, Vol.30 (4), p.317-326

2007

Volltextzugriff (PDF)

No Pharmacokinetic Drug–Drug Interaction Between Prasugrel and Vorapaxar Following Multiple‐Dose Administration in Healthy Volunteers

Clinical pharmacology in drug development, 2018-02, Vol.7 (2), p.143-150

2018

Volltextzugriff (PDF)

ONCE-DAILY ADMINISTRATION OF MOMETASONE FUROATE DRY POWDER INHALER HAS NO SIGNIFICANT EFFECT ON CORTISOL CONCENTRATIONS IN SUBJECTS WITH MILD-TO-MODERATE ASTHMA

Chest, 2007-10, Vol.132 (4), p.479A-479A

2007

Volltextzugriff (PDF)

Vorapaxar, an oral PAR-1 receptor antagonist, does not affect the pharmacokinetics and pharmacodynamics of warfarin

European journal of clinical pharmacology, 2012-11, Vol.68 (11), p.1509-1516

2012

Volltextzugriff (PDF)

Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin

British journal of clinical pharmacology, 2002-09, Vol.54 (3), p.309-319

2002

Volltextzugriff (PDF)

Effect of the thrombin receptor antagonist (PAR-1) vorapaxar on QT/QTc interval in healthy volunteers: A randomized, placebo- and positive-controlled, parallel group trial

Clinical pharmacology in drug development, 2014-01, Vol.3 (1), p.18-24

2014

Volltextzugriff (PDF)

Effect of Food, Antacid, and Age on the Pharmacokinetics of the Oral Thrombin Receptor Antagonist Vorapaxar (SCH 530348) in Healthy Volunteers

Clinical pharmacology in drug development, 2013-07, Vol.2 (3), p.223-230

2013

Volltextzugriff (PDF)

The Influence of Multiple-Dose Vorapaxar, an Oral PAR-1 Receptor Antagonist, on the Single-Dose Pharmacokinetics and Pharmacodynamics of Digoxin

Clinical pharmacology in drug development, 2013-01, Vol.2 (1), p.90-98

2013

Volltextzugriff (PDF)

The Absence of a Clinically Significant Effect of Food on the Single Dose Pharmacokinetics of Vorapaxar, a PAR-1 Antagonist, in Healthy Adult Subjects

Clinical pharmacology in drug development, 2013-10, Vol.2 (4), p.310-315

2013

Volltextzugriff (PDF)

Trimethoprim alters the disposition of procainamide and N‐acetylprocainamide

Clinical pharmacology and therapeutics, 1988-10, Vol.44 (4), p.467-477

1988

Volltextzugriff (PDF)

Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatin

Current medical research and opinion, 2004-06, Vol.20 (6), p.955-965

2004

Volltextzugriff (PDF)

Pharmacodynamic and pharmaco-kinetic interaction between fenofibrate and ezetimibe

Current medical research and opinion, 2004-08, Vol.20 (8), p.1197-1207

2004

Volltextzugriff (PDF)

Endopeptidase 24.11 Inhibition by SCH 42495 in Essential Hypertension

Hypertension (Dallas, Tex. 1979), 1993-07, Vol.22 (1), p.119-126

1993

Volltextzugriff (PDF)

Pharmacokinetics of loratadine and pseudoephedrine following single and multiple doses of once- versus twice-daily combination tablet formulations in healthy adult males

Clinical therapeutics, 1997-09, Vol.19 (5), p.1002-1012

1997

Volltextzugriff (PDF)

Influence of Food on the Oral Bioavailability of Loratadine and Pseudoephedrine from Extended-Release Tablets in Healthy Volunteers

Journal of clinical pharmacology, 1996-10, Vol.36 (10), p.923-930

1996

Volltextzugriff (PDF)

Clearance receptors and endopeptidase : equal role in natriuretic peptide metabolism in heart failure

American journal of physiology. Heart and circulatory physiology, 1997-11, Vol.42 (5), p.H2372-H2379

1997

Volltextzugriff (PDF)

Disposition of 14C-eptifibatide after intravenous administration to healthy men

Clinical therapeutics, 1998-03, Vol.20 (2), p.307-323

1998

Volltextzugriff (PDF)

Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers

Clinical pharmacology and therapeutics, 1991-08, Vol.50 (1), p.181-191

1991

Volltextzugriff (PDF)

Pharmacokinetics of isosorbide-5-mononitrate after oral administration of an extended-release mononitrate formulation versus a standard dinitrate formulation

Clinical therapeutics, 1995-03, Vol.17 (2), p.241-251

1995

Volltextzugriff (PDF)

Effect of Food on the Oral Bioavailability of Isosorbide-5-Mononitrate Administered as an Extended-Release Tablet

Journal of clinical pharmacology, 1995-02, Vol.35 (2), p.151-158

1995

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(20)
Pharmacology & Pharmacy
(18)
Biological And Medical Sciences
(16)
Humans
(16)
Medical Sciences
(16)
Pharmacology. Drug Treatments
(15)
Male
(14)
Adult
(13)
Pharmacokinetics
(10)
Drug Interactions
(8)
Biological Availability
(7)
Vorapaxar
(6)
Ezetimibe
(5)
Par-1
(5)
Pharmacodynamics
(5)
Administration, Oral
(4)
Anticholesteremic Agents - Pharmacokinetics
(4)
Azetidines - Pharmacokinetics
(4)
Cardiovascular System
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humans

Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects

HPA Axis Effects of Mometasone Furoate/Formoterol (MF/F) Versus Fluticasone Propionate/Salmeterol (FP/S) Administered via Metered-Dose Inhaler (MDI

A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study

Ezetimibe : A review of its metabolism, pharmacokinetics and drug interactions

Mometasone furoate nasal spray : A review of safety and systemic effects

No Pharmacokinetic Drug–Drug Interaction Between Prasugrel and Vorapaxar Following Multiple‐Dose Administration in Healthy Volunteers

ONCE-DAILY ADMINISTRATION OF MOMETASONE FUROATE DRY POWDER INHALER HAS NO SIGNIFICANT EFFECT ON CORTISOL CONCENTRATIONS IN SUBJECTS WITH MILD-TO-MODERATE ASTHMA

Vorapaxar, an oral PAR-1 receptor antagonist, does not affect the pharmacokinetics and pharmacodynamics of warfarin

Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin

Effect of the thrombin receptor antagonist (PAR-1) vorapaxar on QT/QTc interval in healthy volunteers: A randomized, placebo- and positive-controlled, parallel group trial

Effect of Food, Antacid, and Age on the Pharmacokinetics of the Oral Thrombin Receptor Antagonist Vorapaxar (SCH 530348) in Healthy Volunteers

The Influence of Multiple-Dose Vorapaxar, an Oral PAR-1 Receptor Antagonist, on the Single-Dose Pharmacokinetics and Pharmacodynamics of Digoxin

The Absence of a Clinically Significant Effect of Food on the Single Dose Pharmacokinetics of Vorapaxar, a PAR-1 Antagonist, in Healthy Adult Subjects

Trimethoprim alters the disposition of procainamide and N‐acetylprocainamide

Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatin

Pharmacodynamic and pharmaco-kinetic interaction between fenofibrate and ezetimibe

Endopeptidase 24.11 Inhibition by SCH 42495 in Essential Hypertension

Pharmacokinetics of loratadine and pseudoephedrine following single and multiple doses of once- versus twice-daily combination tablet formulations in healthy adult males

Influence of Food on the Oral Bioavailability of Loratadine and Pseudoephedrine from Extended-Release Tablets in Healthy Volunteers

Clearance receptors and endopeptidase : equal role in natriuretic peptide metabolism in heart failure

Disposition of 14C-eptifibatide after intravenous administration to healthy men

Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers

Pharmacokinetics of isosorbide-5-mononitrate after oral administration of an extended-release mononitrate formulation versus a standard dinitrate formulation

Effect of Food on the Oral Bioavailability of Isosorbide-5-Mononitrate Administered as an Extended-Release Tablet

Aktive Filter

Suchergebnisse filtern